PRECIGEN, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PRECIGEN, INC. (PGEN) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$17.81 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2015-08-10
- PRECIGEN, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-06-30 was $8.22M.
- PRECIGEN, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-03-31 was -$26.03M, a 200.69% decline year-over-year.
- PRECIGEN, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-09-30 was -$39.75M.
- PRECIGEN, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-06-30 was -$22.60M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month |
|---|---|---|---|
| 2015-06-30 | $8.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$17.81M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$26.03M 10-Q · filed 2015-05-11 | ||
| 2014-09-30 | -$39.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$62.35M derived: sum of 2 quarters · filed 2015-08-10 | -$36.49M 10-Q · filed 2014-11-13 |
| 2014-06-30 | -$22.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $3.26M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $25.86M 10-Q · filed 2015-05-11 | ||
| 2013-09-30 | -$126.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$222.24M derived: sum of 2 quarters · filed 2014-11-13 | -$221.70M 10-Q · filed 2014-11-13 |
| 2013-06-30 | -$95.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$95.31M 10-Q · filed 2014-08-14 | |
| 2013-03-31 | $531.00K 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |